CCR7 plays critical roles in enabling tumor cells accessing and establishing tumor microenvironments (TME), e.g. shown in syngeneic models of Burkitt lymphoma [43] where genetic deletion of CCR7 delayed arrival at such milieus and niche formation, and impaired cross-talk between malignant and accessory cells [43]. The gene discussed is CCR7; the disease is neoplasm.